Clinical Trial Update: A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating HS219 in chronic kidney disease patients on hemodialysis with hyperphosphatemia; the trial completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• HS219

Snippet

Sponsor: KDL Inc. | Conditions: Hyperphosphatemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-06-01